(HealthDay)—The frequency of relapse-free cure from multidrug-resistant tuberculosis (MDR-TB) is higher than previously anticipated, according to a study published in the Aug. 1issue of the American Journal of Respiratory and Critical Care Medicine. Gunar Günther, M.D., M.P.H., from the German Center for Infection Research in Borstel, and colleagues documented the management and treatment outcomes of patients with...